Therefore, it remains to be investigated whether SOX4 interacts with the non-SMAD TGF-β signaling to regulate β-catenin activity for promotion of cell proliferation in pancreatic cancer. This evidence concerns the gene SOX4 and familial pancreatic carcinoma.